KIT and neoplasm: Protooncogene c-KIT/CD117 is known as the mast/stem cell factor receptor and receptor tyrosine kinase, and its activation in CSCs may regulate the stemness to control tumor progression and drug resistance to tyrosine kinase inhibitors.